REVIEW article
Front. Immunol.
Sec. Autoimmune and Autoinflammatory Disorders: Autoinflammatory Disorders
This article is part of the Research TopicBehçet’s Syndrome: From Pathophysiology to Personalized TherapeuticsView all articles
Towards a basis for Vascular versus Intestinal Phenotype Differences; East Meets West in Behcet’s Disease
Provisionally accepted
- 1University of Leeds, Leeds, United Kingdom
- 2Marmara Universitesi, Istanbul, Türkiye
- 3Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Phenotypic differences in disease expression across ethnic populations may hold the key to a better understanding of the pathophysiology of Behçet's disease (BD), which has a wide geographical distribution and marked clinical variability between East Asian, Middle Eastern, and Western countries. In contrast to the predominance of vascular involvement in regions such as Turkey, intestinal involvement is more frequently observed in East Asian patients, particularly in Japan. Genome-wide association studies in inflammatory bowel disease (IBD), which shows clinical similarity to BD, have identified NOD2 and IL23R variants as major susceptibility loci in European populations. However, the relative absence of these IBD-related variants in East Asian populations, where intestinal BD is more prevalent, suggests the presence of alternative, BD-specific mechanisms driving gut involvement in different genetic backgrounds. Here]n, we argue that this diversity in BD clinical expression may also reflect underlying differences in innate immune responses, particularly involving IL-1 signaling pathways. The striking prominence of MEFV variants (approximately 20% carrier frequency) in Turkish populations where vascular BD is more common, compared with their relative scarcity in East Asia, may offer important clues as to how population-specific genetic backgrounds shape distinct inflammatory phenotypes. In this article, we discuss these immunogenetic contrasts in relation to clinical heterogeneity, with a particular focus on the IL-1 pathway regulated by MEFV, to provide a more nuanced understanding of ethnic differences in BD pathogenesis and their implications for future therapeutic strategies.
Keywords: Behcet disease, Inflammatory bowel disease, Intestinal Development, MEFV, Vasculitis
Received: 01 Dec 2025; Accepted: 12 Feb 2026.
Copyright: © 2026 Abacar, Macleod, ALIBAZ-ONER, Direskeneli and McGonagle. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Kerem Abacar
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.